Standout Papers
Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Spectral Fluorescence Molecular Imaging of Lung Metastases Targeting HER2/neu
2007
Engineering precision nanoparticles for drug delivery
2020 Standout
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
2010
EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies
2011
Molecular imaging in drug development
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials
2011
True
2000
Osteosarcoma: Review of the Past, Impact on the Future. The American Experience
2009
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients
2011
Drug-targeting strategies in cancer therapy
2001
The Role of β-Glucuronidase in Drug Disposition and Drug Targeting in Humans
1997
Imaging in the era of molecular oncology
2008 StandoutNature
Prodrug Strategies in Anticancer Chemotherapy
2007
Stereotactic body radiation therapy for oligometastases
2009
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
Amputation for soft-tissue sarcoma
2003
The biology and function of fibroblasts in cancer
2016 Standout
Spontaneous Pneumothorax
2000 Standout
Local Surgical, Ablative, and Radiation Treatment of Metastases
2009
Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients
2010
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system
2012
Soft-Tissue Sarcomas in Adults
2005 Standout
Photodynamic therapy for cancer
2003 Standout
Colorectal cancer
2013 Standout
Osteosarcoma
2010 Standout
Osteosarcoma in very young children
2010
Monoclonal antibody drug immunoconjugates for targeted treatment of cancer
2003
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Antibody therapy of cancer
2012 Standout
Osteosarcoma Lung Metastases Detection and Principles of Multimodal Therapy
2009
Antiangiogenic therapy—evolving view based on clinical trial results
2012
Polymer conjugates as anticancer nanomedicines
2006 Standout
Intrapleural Talc for the Prevention of Recurrent Pneumothorax
1994
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)
2008
Osteosarcoma: The COSS Experience
2009
Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation
2011
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
2013
3D bioprinting of tissues and organs
2014 Standout
Nasopharyngeal carcinoma
2015 Standout
Efficiency of Video-Assisted Thoracic Surgery for Primary and Secondary Spontaneous Pneumothorax
1998
Polyphenols: food sources and bioavailability
2004 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.
1995
Natural Product Hybrids as New Leads for Drug Discovery
2003 Standout
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Common pitfalls in preclinical cancer target validation
2017 StandoutNobel
Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate
2013
Recent developments in the field of antitumour anthracyclines
2001
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
2019
Microenvironmental regulation of metastasis
2008 Standout
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells
2012
Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone DI-N-oxide prodrug
1998
Midterm Local Efficacy and Survival after Radiofrequency Ablation of Lung Tumors with Minimum Follow-up of 1 Year: Prospective Evaluation
2006
Stereotactic Single-Dose Radiotherapy of Lung Metastases
2007
Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
1997
Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment
1999
Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism
2003
Metabolite profiles and the risk of developing diabetes
2011 Standout
Galectin expression in cancer diagnosis and prognosis: A systematic review
2015
Improving Paclitaxel Delivery:In VitroandIn VivoCharacterization of PEGylated Polyphosphoester-Based Nanocarriers
2015
Modes of resistance to anti-angiogenic therapy
2008 Standout
The role of pulmonary metastasectomy in soft tissue sarcoma
2002
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer
2001
Gut Microbiota in Health and Disease
2010 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?
2013
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
2013
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
2003
Progress and prospects of early detection in lung cancer
2017
18F-FDG PET/CT Imaging In Oncology
2011
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Fibroblast heterogeneity in the cancer wound
2014
An Activity-Based Near-Infrared Glucuronide Trapping Probe for Imaging β-Glucuronidase Expression in Deep Tissues
2012
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Works of Godehard Friedel being referenced
Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin
2012
Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients
2008
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
2010
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
2006
Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon
2011
Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: Is there any prognostic relevance?
1999
Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast
2008
Video-Assisted Thoracoscopic Pleurodesis
1996
Prerequisites, Indications, and Techniques of Video-assisted Thoracoscopic Surgery
1993
Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer
2000
Distinct angiogenic and non‐angiogenic growth patterns of lung metastases from renal cell carcinoma
2007
Locoregional Therapy
2010
Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase
2002
Solitary Pulmonary Nodules: Dynamic Contrast-enhanced MR Imaging—Perfusion Differences in Malignant and Benign Lesions
2004
Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancer
1997
Generation and Transplantation of an Autologous Vascularized Bioartificial Human Tissue
2009
[Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases].
1999
Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue
1995
Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site.
1997
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases
1997 Standout